Microfluidic platform for diabetes drug testing covered in ETH Industry News
Article on new microfluidic testing platform that will help diabetes researchers to find new drugs and to get deeper insights into underlying biological mechanisms in ETH Industry News.
Recent work on perfusion of human pancreatic-islet microtissues, produced by InSphero, in microfluidic organ-on-a-chip platforms, developed at BEL, was covered in an interview of ETH Industry News with Patrick Misun (BEL) and Burcak Yesildag (InSphero). The developed platform technology opens new prospects for diabetes research and represents a powerful tool for studying insulin release dynamics at high temporal resolution.
ETH Industry News is published by ETH Industry Relations, which supports companies in finding partners and organize visits, lab tours, workshops, and events at ETH Zurich. ETH Industry Relations also offer services for small and medium-sized enterprises.
external page InSphero Press Release
external page Original Research Article in Advanced Biosystems